Is there an obesity-metabolic syndrome related glomerulopathy?

Current Opinion in Nephrology and Hypertension

Volumn 20, Issue 1, 2011, Pages 44-49

  Ritz, Eberhard ^a   Koleganova, Nadezda ^a   Piecha, Grzegorz ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Bariatric surgery; Focal segmental glomerulosclerosis; Morbid obesity; Nephrotic syndrome

Indexed keywords

ADIPONECTIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INSULIN; MINERALOCORTICOID RECEPTOR; REACTIVE OXYGEN METABOLITE;

ALBUMINURIA; ARTICLE; BARIATRIC SURGERY; BODY MASS; DISEASE COURSE; FOCAL GLOMERULOSCLEROSIS; GENE EXPRESSION; GENETIC ASSOCIATION; GLOMERULAR DYSFUNCTION; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; KIDNEY BIOPSY; KIDNEY FUNCTION; METABOLIC SYNDROME X; MORBID OBESITY; NEPHROTIC SYNDROME; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEINURIA; RISK ASSESSMENT; RISK FACTOR; SURVIVAL RATE; WAIST CIRCUMFERENCE; WEIGHT REDUCTION;

ANIMALS; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; KIDNEY; METABOLIC SYNDROME X; OBESITY;

EID: 79851511606     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/MNH.0b013e3283414ca1     Document Type: Article

References (56)

1. Haslam DW, James WP. Obesity. Lancet 2005; 366:1197-1209. (Pubitemid 41393598)
2. Jia WP, Wang C, Jiang S, Pan JM. Characteristics of obesity and its related disorders in China. Biomed Environ Sci 2010; 23:4-11.
3. Conard NJ. A female figurine from the basal Aurignacian of Hohle Fels Cave in southwestern Germany. Nature 2009; 459:248-252.
4. Hitzenberger K, Richter-Quittner M. A report on metabolism in vascular hypertension. Wiener Archiv Innere Medizin 1921; 2:189-199.
5. Kylin E. Hypertension-hyperglycemia-hyperuricemia. Zentralblatt fur Innere Medizin 1923; 44:105-120.
6. Preble WE. Obesity: observations of 1,000 cases. Boston Med Surg J 1923; 188:617-621.
7. Weisinger JR, Kempson RL, Eldridge FL, Swenson RS. The nephrotic syndrome: a complication of massive obesity. Ann Intern Med 1974; 81:440-447.
8. Cohen AH. Massive obesity and the kidney. A morphologic and statistical study. Am J Pathol 1975; 81:117-130.
9. Jennette JC, Charles L, Grubb W. Glomerulomegaly and focal segmental glomerulosclerosis associated with obesity and sleep-apnea syndrome. Am J Kidney Dis 1987; 10:470-472. (Pubitemid 18007347)
10. Kasiske BL, Crosson JT. Renal disease in patients with massive obesity. Arch Intern Med 1986; 146:1105-1109. (Pubitemid 16042155)
11. Warnke RA, Kempson RL. The nephrotic syndrome in massive obesity: a study by light, immunofluorescence, and electron microscopy. Arch Pathol Lab Med 1978; 102:431-438. (Pubitemid 9004033)
12. Verani RR. Obesity-associated focal segmental glomerulosclerosis: pathological features of the lesion and relationship with cardiomegaly and hyperlipidemia. Am J Kidney Dis 1992; 20:629-634. (Pubitemid 23031716)
13. Bailey RR, Lynn KL, Burry AF, Drennan C. Proteinuria, glomerulomegaly and focal glomerulosclerosis in a grossly obese man with obstructive sleep apnea syndrome. Aust N Z J Med 1989; 19:473-474. (Pubitemid 19276110)
14. Wesson DE, Kurtzman NA, Frommer JP. Massive obesity and nephrotic proteinuria with a normal renal biopsy. Nephron 1985; 40:235-237. (Pubitemid 15064581)
15. Kambham N, Markowitz GS, Valeri AM, et al. Obesity-related glomerulopathy: an emerging epidemic. Kidney Int 2001; 59:1498-1509. (Pubitemid 32281241)
16. Praga M, Hernandez E, Morales E, et al. Clinical features and long-term outcome of obesity-associated focal segmental glomerulosclerosis. Nephrol Dial Transplant 2001; 16:1790-1798. (Pubitemid 32821410)
17. Praga M. Synergy of low nephron number and obesity: a new focus on hyperfiltration nephropathy. Nephrol Dial Transplant 2005; 20:2594-2597. (Pubitemid 41672251)
18. Srivastava T. Nondiabetic consequences of obesity on kidney. Pediatr Nephrol 2006; 21:463-470.
19. Chen HM, Li SJ, Chen HP, et al. Obesity-related glomerulopathy in China: a case series of 90 patients. Am J Kidney Dis 2008; 52:58-65.
20. Chen HM, Liu ZH, Zeng CH, et al. Podocyte lesions in patients with obesityrelated glomerulopathy. Am J Kidney Dis 2006; 48:772-779.
21. Wu Y, Liu Z, Xiang Z, et al. Obesity-related glomerulopathy: insights from gene expression profiles of the glomeruli derived from renal biopsy samples. Endocrinology 2006; 147:44-50. (Pubitemid 43004261)
22. Bakker SJ, Gansevoort RT, de Zeeuw D. Metabolic syndrome: a fata morgana? Nephrol Dial Transplant 2007; 22:15-20. (Pubitemid 46050318)
23. Hsu CY, McCulloch CE, Iribarren C, et al. Body mass index and risk for endstage renal disease. Ann Intern Med 2006; 144:21-28. (Pubitemid 46780716)
24. Iseki K, Ikemiya Y, Kinjo K, et al. Body mass index and the risk of development of end-stage renal disease in a screened cohort. Kidney Int 2004; 65:1870-1876. (Pubitemid 38591038)
25. Praga M. Obesity-a neglected culprit in renal disease. Nephrol Dial Transplant 2002; 17:1157-1159. (Pubitemid 34812055)
26. Gonzalez E, Gutierrez E, Morales E, et al. Factors influencing the progression of renal damage in patients with unilateral renal agenesis and remnant kidney. Kidney Int 2005; 68:263-270. (Pubitemid 43181384)
27. Bonnet F, Deprele C, Sassolas A, et al. Excessive body weight as a new independentrisk factor for clinical and pathological progression in primary IgA nephritis. Am J Kidney Dis 2001; 37:720-727. (Pubitemid 32268032)
28. Meier-Kriesche HU, Arndorfer JA, Kaplan B. The impact of body mass index on renal transplant outcomes: a significant independent risk factor for graft failure and patient death. Transplantation 2002; 73:70-74. (Pubitemid 34094688)
29. Gross ML, Amann K, Ritz E. Nephron number and renal risk in hypertension and diabetes. J Am Soc Nephrol 2005; 16 (Suppl 1):S27-S29. (Pubitemid 41725078)
30. Brenner BM, Garcia DL, Anderson S. Glomeruli and blood pressure. Less of one, more the other? Am J Hypertens 1988; 1:335-347.
31. Henegar JR, Bigler SA, Henegar LK, et al. Functional and structural changes in the kidney in the early stages of obesity. J Am Soc Nephrol 2001; 12:1211-1217. (Pubitemid 32472634)
32. Chagnac A, Weinstein T, Korzets A, et al. Glomerular hemodynamics in severe obesity. Am J Physiol Renal Physiol 2000; 278:F817-822. (Pubitemid 30351084)
33. Tomaszewski M, Charchar FJ, Maric C, et al. Glomerular hyperfiltration: a new marker of metabolic risk. Kidney Int 2007; 71:816-821. (Pubitemid 46624026)
34. Bosma RJ, van der Heide JJ, Oosterop EJ, et al. Bodymass indexis associated with altered renal hemodynamics in nonobese healthy subjects. Kidney Int 2004; 65:259-265. (Pubitemid 38037512)
35. D'Agati VD, Markowitz GS. Supersized kidneys: lessons from the preclinical obese kidney. Kidney Int 2008; 73:909-910. (Pubitemid 351458320)
36. Krikken JA, Lely AT, Bakker SJ, Navis G. The effect of a shift in sodium intake on renal hemodynamics is determined by body mass index in healthy young men. Kidney Int 2007; 71:260-265. (Pubitemid 46160927)
37. Dengel DR, Goldberg AP, Mayuga RS, et al. Insulin resistance, elevated glomerular filtration fraction, and renal injury. Hypertension 1996; 28:1 27-132.
38. Sowers JR, Whaley-Connell A, Epstein M. Narrative review: the emerging clinical implications of the role of aldosterone in the metabolic syndrome and resistant hypertension. Ann Intern Med 2009; 150:776-783.
39. Shibata S, Nagase M, Yoshida S, et al. Modification of mineralocorticoid receptor function by Rac1 GTPase: implication in proteinuric kidney disease. Nat Med 2008; 14:1370-1376.
40. Fedorova LV, Raju V, El-Okdi N, et al. The cardiotonic steroid hormone marinobufagenin induces renal fbrosis: implication of epithelial-to-mesenchymal transition. Am J Physiol Renal Physiol 2009; 296:F922-934.
41. Nagase M, Shibata S, Yoshida S, et al. Podocyte injury underlies the glomerulopathy of Dahl salt-hypertensive rats and is reversed by aldosterone blocker. Hypertension 2006; 47:1084-1093. (Pubitemid 44289165)
42. Nagase M, Yoshida S, Shibata S, et al. Enhanced aldosterone signaling in the early nephropathy of rats with metabolic syndrome: possible contribution of fat-derived factors. J Am Soc Nephrol 2006; 17:3438-3446. (Pubitemid 44865286)
43. Sharma K, Ramachandrarao S, Qiu G, et al. Adiponectin regulates albuminuria and podocyte function in mice. J Clin Invest 2008; 118:1645-1656. (Pubitemid 351632369)
44. Ix JH, Sharma K. Mechanisms linking obesity, chronic kidneydisease, and fatty liver disease: the roles of fetuin-A, adiponectin, and AMPK. J Am Soc Nephrol 2010; 21:406-412.
45. Afshinnia F, Wilt TJ, Duval S, Esmaeili A, Ibrahim HN. Weight loss and proteinuria: systematic review of clinical trials and comparative cohorts. Nephrol Dial Transplant 2010; 25:1173-1183.
46. Morales E, Valero MA, Leon M, et al. Beneficial effects of weight loss in overweight patients with chronic proteinuric nephropathies. Am J Kidney Dis 2003; 41:319-327. (Pubitemid 36152449)
47. Georgaki-Angelaki H, Stergiou N, Manolaki N, et al. Histological deterioration of obesity-related glomerulopathy despite the loss of proteinuria with weight reduction. Pediatr Nephrol 2010; 25:1573-1574.
48. Chagnac A, Weinstein T, Herman M, et al. The effects of weight loss on renal function in patients with severe obesity. J Am Soc Nephrol 2003; 14:1480-1486. (Pubitemid 36687049)
49. Alexander JW, Goodman HR, Hawver LR, Cardi MA. Improvement and stabilization of chronic kidney disease after gastric bypass. Surg Obes Relat Dis 2009; 5:237-241.
50. Agrawal V, Khan I, Rai B, et al. The effect of weight loss after bariatric surgery on albuminuria. Clin Nephrol 2008; 70:194-202.
51. Fowler SM, Kon V, Ma L, et al. Obesity-related focal and segmental glomerulosclerosis: normalization of proteinuria in an adolescent after bariatric surgery. Pediatr Nephrol 2009; 24:851-855.
52. Romero-Corral A, Somers VK, Sierra-Johnson J, et al. Normal weight obesity: a risk factor for cardiometabolic dysregulation and cardiovascular mortality. Eur Heart J 2010; 31:737-746.
53. Pinto-Sietsma SJ, Navis G, Janssen WM, et al. A central body fat distribution is related to renal function impairment, even in lean subjects. Am J Kidney Dis 2003; 41:733-741. (Pubitemid 36401550)
54. Bonnet F, Marre M, Halimi JM, et al. Waist circumference and the metabolic syndrome predict the development of elevated albuminuria in nondiabetic subjects: the DESIR Study. J Hypertens 2006; 24:1157-1163. (Pubitemid 43772324)
55. Serra A, Romero R, Lopez D, et al. Renal injury in the extremely obese patients with normal renal function. Kidney Int 2008; 73:947-955. (Pubitemid 351458316)
56. Alexander MP, Patel TV, Farag YM, et al. Kidney pathological changes in metabolic syndrome: a cross-sectional study. Am J Kidney Dis 2009; 53:751-759.